McKesson Corporation (mck)
MCK Earnings
Public earnings and growth snapshot for McKesson Corporation. Full earnings calendars, surprises, and multi-year history are available in Vest Terminal.
| Earnings growth (YoY) | -17.6% |
| Revenue growth (YoY) | 7.7% |
| Trailing P/E | 23.47 |
| Forward P/E | 17.45 |
| Last price | $880.50 |
| Market cap | $102.66B |
Start Free — open MCK in Vest Terminal
Access live data, filings, ownership, and analysis for McKesson Corporation.
McKesson Corporation FAQ
What does McKesson Corporation (MCK) do?
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes bra…
What is MCK's P/E ratio?
McKesson Corporation has a trailing P/E of 23.47× based on publicly available market data.
Does MCK pay a dividend?
Indicated dividend yield: 0.4%. Confirm ex-dates and payout history in Vest Terminal.
What sector is MCK in?
McKesson Corporation is classified in Healthcare (Medical Distribution) on NYQ.
What is MCK's market capitalization?
Approximate market cap: $102.66B.
What are the main risks for MCK?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of MCK?
Potential positives include revenue growth of 7.7% year-over-year, positive free cash flow ($6.80b).
Where can I get analyst estimates for MCK?
Public analyst price targets and consensus for McKesson Corporation are on the free /stocks/mck/estimates page. Deeper estimate history and models are available in Vest Terminal.